tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MYGN Stock Latest News

Myriad says GeneSight Psychotropic Test led to fewer hospitalizations in study
The FlyMyriad says GeneSight Psychotropic Test led to fewer hospitalizations in study
5d ago
MYGN
Myriad Genetics price target lowered to $9 from $11 at BofA
PremiumThe Fly
Myriad Genetics price target lowered to $9 from $11 at BofA
12d ago
MYGN
Myriad Genetics downgraded to Neutral from Buy at Guggenheim
PremiumThe Fly
Myriad Genetics downgraded to Neutral from Buy at Guggenheim
17d ago
MYGN
Myriad Genetics appoints Brian Donnelly as CCO
PremiumThe Fly
Myriad Genetics appoints Brian Donnelly as CCO
19d ago
MYGN
Myriad Genetics price target lowered to $20 from $24 at Scotiabank
PremiumThe Fly
Myriad Genetics price target lowered to $20 from $24 at Scotiabank
25d ago
MYGN
Buy Rating on Myriad Genetics: Strategic Changes and Growth Potential Amid Challenges
PremiumRatingsBuy Rating on Myriad Genetics: Strategic Changes and Growth Potential Amid Challenges
2M ago
MYGN
Myriad Genetics upgraded to Overweight from Neutral at Piper Sandler
Premium
The Fly
Myriad Genetics upgraded to Overweight from Neutral at Piper Sandler
2M ago
MYGN
Myriad Genetics price target lowered to $16 from $21 at Morgan Stanley
Premium
The Fly
Myriad Genetics price target lowered to $16 from $21 at Morgan Stanley
2M ago
MYGN
Myriad Genetics price target lowered to $11.50 from $14 at Piper Sandler
PremiumThe Fly
Myriad Genetics price target lowered to $11.50 from $14 at Piper Sandler
2M ago
MYGN
Myriad Genetics price target lowered to $11 from $13 at BofA
PremiumThe Fly
Myriad Genetics price target lowered to $11 from $13 at BofA
2M ago
MYGN
Myriad Genetics Faces Financial Uncertainty Amid Potential Tax Law Changes
PremiumCompany Announcements
Myriad Genetics Faces Financial Uncertainty Amid Potential Tax Law Changes
2M ago
MYGN
Myriad Genetics Reports Strong Growth Amid Challenges
PremiumCompany Announcements
Myriad Genetics Reports Strong Growth Amid Challenges
2M ago
MYGN
Cautious Outlook for Myriad Genetics Amid Leadership Transition and Revised Growth Projections
PremiumRatingsCautious Outlook for Myriad Genetics Amid Leadership Transition and Revised Growth Projections
2M ago
MYGN
Myriad Genetics price target lowered to $19 from $27 at Raymond James
Premium
The Fly
Myriad Genetics price target lowered to $19 from $27 at Raymond James
2M ago
MYGN
Myriad Genetics price target lowered to $16 from $17 at TD Cowen
Premium
The Fly
Myriad Genetics price target lowered to $16 from $17 at TD Cowen
2M ago
MYGN
Myriad Genetics Reports Strong Revenue Growth in 2024
PremiumCompany Announcements
Myriad Genetics Reports Strong Revenue Growth in 2024
2M ago
MYGN
Hold Rating on Myriad Genetics Amid Leadership Transition and Adjusted Revenue Expectations
PremiumRatings
Hold Rating on Myriad Genetics Amid Leadership Transition and Adjusted Revenue Expectations
2M ago
MYGN
Myriad Genetics Announces CEO Transition in 2025
PremiumCompany Announcements
Myriad Genetics Announces CEO Transition in 2025
2M ago
8K
MYGN
Myriad Genetics CEO Paul Diaz to depart, Sam Raha to succeed
PremiumThe Fly
Myriad Genetics CEO Paul Diaz to depart, Sam Raha to succeed
2M ago
MYGN
Myriad Genetics sees FY25 adjusted EPS 7c-11c, consensus 6c
PremiumThe FlyMyriad Genetics sees FY25 adjusted EPS 7c-11c, consensus 6c
2M ago
MYGN
Myriad Genetics reports Q4 adjusted EPS 3c, consensus 3c
Premium
The Fly
Myriad Genetics reports Q4 adjusted EPS 3c, consensus 3c
2M ago
MYGN
Myriad Genetics sees Q1 adjusted EPS (8c)-(4c), consensus (2c)
Premium
The Fly
Myriad Genetics sees Q1 adjusted EPS (8c)-(4c), consensus (2c)
2M ago
MYGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >